康脂素药业有限责任公司创业计划书.doc

康脂素药业有限责任公司 创 业 计 划 书 保 密 承 诺 本计划书涉及公司商业机密，所有权属于零点科技湖北分公司，其所涉及的内容和资料只限于与本项目有意向的合作伙伴传阅，在您收到本计划书后，应立刻确认，并请遵守： 1、未经本公司书面授权，严禁将本计划书部分或全部拷贝、影印、复印、散发给第三方，也不得向第三方泄露本计划书涉及的部分或全部内容。 2、若您确认放弃本计划书涉及项目，请您及时将本计划书归还本公司，或将本计划书作适当处理。 3、本承诺书一式两份，请您像对待贵公司的商业机密一样对待本计划书提供的所有机密资料，否则将追究相关法律责任。 投资单位盖章: 接收经理签字： 接 收 日 期： _______年____月____日 目　录 第一章：执行概要 一、公司简介·················································································06 二、市场描述·················································································06 三、公司管理·················································································08 四、公司战略规划··········································································08 五、场地及设施·············································································08 六、投资与财务·············································································08 第二章：康脂素新药研究 一、产品来源·················································································09 二、原料来源·················································································09 三、新药研究·················································································09 临床前研究···············································································10 剂量的选择···············································································27 康脂素质量标准起草说明····························································28 产品生产工艺···········································································36 产品包装·················································································38 品种规划·················································································38 第三章：生产质量管理 一、生产管理·················································································39 二、生产要求·················································································40 三、厂房建设·················································································41 四、成本控制···································